Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant Bristol-Myers Squibb Pharma EEIG, against the decision of the State Institute for Drug Control from e 3. 3. 2020, under the no. SUKLS298091/2019:

• the remainder of the appeal is dismissed and the decision under appeal is upheld.

More information: MZCR.cz.